Table 1 Study group characteristics – demographic and clinical data.
Whole group (n = 4071) | Females | Males | P value | |||||||
---|---|---|---|---|---|---|---|---|---|---|
All (n = 1888) | Survivors (n = 1739) | Nonsurvivors (n = 149) | P value | All (n = 2183) | Survivors (n = 1996) | Nonsurvivors (n = 187) | P value | Females vs. Males | ||
Age* (years) | 59.7 (16.2) | 63.0 (49.0–73.0) | 62 (47.5–72.0) | 78.0 (69.5–85.0) | < 0.001 | 61.0 (48.0–70.0) | 59.0 (47.0–68.0) | 71.0 (63.0–80.0) | < 0.001 | < 0.001 |
BMI* (kg/m2) | 29.0 (5.5) | 28.4 (24.6–32.0) | 28.9 (5.6) | 27.7 (6.0) | 0.08 | 28.4 (25.7–31.9) | 28.4 (25.8–32.0) | 26.6 (24.1–30.8) | 0.001 | 0.14 |
SBP* (mmHg) | 132.4 (20.4) | 130.0 (119.0–145.0) | 130.0 (119.0–144.0) | 134.0 (120.0–150.0) | 0.09 | 131.0 (120.0–145.0) | 131.0 (120.0–145.0) | 130.0 (114.0–146.0) | 0.10 | 0.25 |
DBP* (mmHg) | 80.6 (13.3) | 80.0 (71.0–90.0) | 80.0 (71.0–89.0) | 80.0 (70.0–90.0) | 0.51 | 80.0 (73.0–90.0) | 80.0 (73.0–90.0) | 80.0 (70.0–89.0) | 0.003 | 0.06 |
Respiratory rate* (min-1) | 15.4 (4.2) | 14.0 (12.0–16.0) | 14.0 (12.0–16.0) | 15.0 (12.0–18.0) | 0.07 | 14.0 (12.0–18.0) | 14.0 (12.0–17.0) | 15.0 (12.0–19.0) | 0.009 | 0.04 |
Oxygen saturation* (%) | 94.0 (5.1) | 96.0 (93.0–97.0) | 96.0 (93.0–97.0) | 96.0 (94.0–97.0) | 0.30 | 95.0 (92.0–97.0) | 95.0 (92.0–97.0) | 95.0 (92.0–98.0) | 0.024 | < 0.001 |
HR* (min-1) | 85.0 (15.2) | 82.0 (75.0–94.0) | 83.0 (75.0–95.0) | 80.0 (71.5–91.0) | 0.002 | 84.0 (75.0–95.0) | 84.0 (76.0–95.0) | 80.0 (71.0–91.0) | 0.003 | 0.14 |